Adnexi is a pioneering and innovative brand specializing in Key Opinion Leader (KOL) discovery and mapping for the biopharma industry. Our efficient and customized solutions, powered by proprietary software, connect biopharma companies to the most influential KOLs and digital opinion leaders (DOLs) crucial for drug development and launch. Developing strong relationships with KOLs and DOLs is essential for successful drug development, and at Adnexi, we recognize its importance.

We offer tailored, tech-enabled solutions that enable biopharma companies to identify the thought leaders that matter most. Our BASE KOL Discovery utilizes a proprietary algorithm to collect and rank vast amounts of scientific activity data on thought leaders for any disease. This information is used to create comprehensive KOL profiles, including publications, clinical trials, NIH grants, and payments from biopharma.

Through our TRIAL VERSITY service, we identify clinical investigators with access to diverse patient populations, including African American, Asian, and Hispanic patients, ensuring the creation of an FDA Guidelines Diversity Plan for your trial. With our AIM Influence Mapping, we survey community physicians and KOLs to understand their spheres of influence at global, national, and regional levels, assisting you in identifying the top influencers for your disease area. In today's digital world, digital opinion leaders hold significant influence.

Adnexi can identify these leaders, track their online activity, send you real-time alerts, and create strategic engagement plans to maximize your reach. Choose Adnexi and let our expert team help you efficiently discover and map the most relevant KOLs for your specific disease of interest. Trust us to accelerate your work and empower your drug development and launch strategies